Concourse Financial Group Securities, Inc. Kezar Life Sciences, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$0.53 - $0.77 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$0.6 - $0.92 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$0.8 - $1.05 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$0.72 - $1.15 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$1.08 - $2.54 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$1.08 - $2.54 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$2.31 - $3.06 $0 - $0
Q1 2023 May 15, 2023	BUY	$3.13 - $7.31 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$6.39 - $8.8 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$7.99 - $10.75 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$4.58 - $17.13 $0 - $0
Q1 2022 May 09, 2022	BUY	$12.3 - $18.33 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$7.44 - $16.72 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$4.85 - $9.73 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$4.93 - $6.46 $0 - $0
Q1 2021 May 13, 2021	BUY	$5.24 - $6.99 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$4.77 - $6.58 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$4.36 - $5.5 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$3.6 - $7.75 $0 - $0
Q1 2020 May 13, 2020	BUY	$2.77 - $5.75 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$2.5 - $4.26 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$3.0 - $7.58 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$7.09 - $21.9 $0 - $0
Q1 2019 May 15, 2019	BUY	$16.83 - $23.75 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$20.21 - $32.9 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$15.5 - $21.41 $0 - $0

Others Institutions Holding KZR

# of Institutions

Shares Held

38.4M

Call Options Held

13.8K

Put Options Held

600

Suvretta Capital Management, LLC New York, NY

7.17M
Shares

$53.8 Million
0.22% of portfolio
Avidity Partners Management LP Dallas, TX

5.03M
Shares

$37.7 Million
0.24% of portfolio
Tang Capital Management LLC San Diego, CA

3.64M
Shares

$27.3 Million
0.24% of portfolio
Vanguard Group Inc Valley Forge, PA

2.74M
Shares

$20.6 Million
0.0% of portfolio
Affinity Asset Advisors, LLC New York, NY

2.51M
Shares

$18.8 Million
0.33% of portfolio

View Full List

About Kezar Life Sciences, Inc.

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $513M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

More about KZR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account